WideCells Group PLC (‘WideCells’ or the ‘Company’), the healthcare services company focused on providing stem cell services and ground breaking insurance for stem cell treatment, is pleased to announce that Non-Executive Director Dr. Marilyn Orcharton will be representing the Company at the upcoming British Dental Conference and Exhibition, being held in Manchester from 25-27 May 2017. At the conference, Dr. Orcharton will be providing information on the Company’s plans to extend its stem cell storage services to include dental pulp storage and processing (TeethCells). The Company hopes to start offering this new service to the market in the coming months and, having recognised significant growth opportunities within the dental industry, intends to appoint a Dental Key Account Manager to manage this emerging revenue stream including potential strategic relationships with distribution partners in Europe and the Middle-East.
Dr. Orcharton is a renowned figure in dentistry, having co-founded Denplan Limited in 1986, which is still the UK’s market leader in dental insurance, with a multi-million-pound annual turnover. WideCells is looking to achieve similar success in the stem cell industry via its CellPlan division, which is rolling out the world’s first stem cell healthcare insurance plan.
The Company is also developing its WideCells division and is on track to launch its second stem cell storage and contract research facility, the Institute of Stem Cell Technology, located in the University of Manchester Innovation Centre in Q2 2017 (‘the ISCT’). The ISCT will initially offer umbilical cord progressing and storage (BabyCells), like its existing facility in São Paulo, Brazil. However, looking ahead it also plans to obtain a license from the HTA (‘Human Tissue Authority’) to offer dental pulp storage and processing later this year, which involves harvesting stem cells from baby teeth (TeethCells), in line with its strategy to build a diverse service offering to enable the storage of cells for individuals anywhere along the age spectrum, allowing maximum market penetration.
Dr. Orcharton’s established network and experience within the dental industry will be invaluable in supporting the development of this new service offering and the British Dental Conference and Exhibition provides an opportune format through which to connect with industry leaders.
For further information on the conference please visit https://bda.org/conference